A Multicenter, Randomized, Open Label, Parallel Group Study Comparing Pre-discharge and posT-discharge tReatment Initiation With LCZ696 in heArt Failure patieNtS With Reduced ejectIon-fracTion hospItalized for an Acute decOmpensation eveNt (ADHF)
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms TRANSITION
- Sponsors Novartis Pharmaceuticals
- 18 Aug 2017 Planned End Date changed from 17 Jul 2018 to 6 Jun 2018.
- 18 Aug 2017 Planned primary completion date changed from 21 Mar 2018 to 8 Feb 2018.
- 12 May 2017 Planned primary completion date changed from 17 Jul 2018 to 21 Mar 2018.